Prestige to buy Insight Pharma for about $750M

Published



TARRYTOWN, N.Y. (AP) — Medicine distributer Prestige Brands will spend about $750 million to buy the EPT home pregnancy test maker Insight Pharmaceuticals.

The Tarrytown, N.Y., company said Friday that the deal for the privately held company will expand its over-the-counter product portfolio to include products like the yeast infection treatment Monistat and other feminine care products.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.